Key facts
- Notable investors include Shanghai Lingang Economic Development, Daoyuan Capital, Jiangsu Winfast Investment, TF Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Huanxin Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Huanxin Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Huanxin Medical
Developer of interventional medical devices designed to advance treatment options for structural heart and vascular conditions. The company offers a diverse portfolio including structural heart disease devices, surgical accessories, and vascular access products, enabling cardiac specialists and interventional surgeons in China to perform complex procedures with greater precision and clinical efficiency.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2020
- Ownership
- Privately Held (backing)
Huanxin Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Huanxin Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Huanxin Medical in its N-PORT filings yet. We sweep new filings monthly.